Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

Erstveröffentlichung
2002Authors
Fulda, S
Wick, W
Weller, M
Debatin, Klaus-Michael
Wissenschaftlicher Artikel
Published in
Nature Medicine ; 8 (2002), 8. - S. 808-815. - ISSN 1078-8956
Link to publication
https://dx.doi.org/10.1038/nm735Institutions
UKU. Klinik für Kinder- und JugendmedizinSubject headings
[Free subject headings]: trail-induced apoptosis | death receptor | tumoricidal activity | cd95 apo-1/fas | cell-death | smac/diablo | cancer | inhibition | pathways | protein[DDC subject group]: DDC 610 / Medicine & health